[Low dose naltrexone for treatment of pain]. / Lavdosisnaltrexon til smertebehandling
Ugeskr Laeger
; 177(43): V03150248, 2015 Oct 09.
Article
em Da
| MEDLINE
| ID: mdl-26509454
ABSTRACT
Recent years have seen an increasing interest in the use of low dose naltrexone (LDN) for off-label treatment of pain in diseases as fibromyalgia, multiple sclerosis and morbus Crohn. The evidence is poor, with only few randomized double-blind placebo-controlled studies. The studies currently available are reviewed in this paper. LDN could be a potentially useful drug in the future for the treatment of pain in fibromyalgia, but more studies are needed to verify that it is superior to placebo, and currently it cannot be recommended as first-line therapy.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Dor
/
Naltrexona
/
Antagonistas de Entorpecentes
Tipo de estudo:
Clinical_trials
Limite:
Humans
Idioma:
Da
Ano de publicação:
2015
Tipo de documento:
Article